[HTML][HTML] Advances in the development of amorphous solid dispersions: The role of polymeric carriers

J Zhang, M Guo, M Luo, T Cai - Asian Journal of Pharmaceutical Sciences, 2023 - Elsevier
Amorphous solid dispersion (ASD) is one of the most effective approaches for delivering
poorly soluble drugs. In ASDs, polymeric materials serve as the carriers in which the drugs …

Amorphous solubility advantage: theoretical considerations, experimental methods, and contemporary relevance

K Ueda, DE Moseson, LS Taylor - Journal of Pharmaceutical Sciences, 2024 - Elsevier
Twenty-five years ago, Hancock and Parks asked a provocative question:“what is the true
solubility advantage for amorphous pharmaceuticals?” Difficulties in determining the …

Crystallinity: a complex critical quality attribute of amorphous solid dispersions

DE Moseson, LS Taylor - Molecular Pharmaceutics, 2023 - ACS Publications
Does the performance of an amorphous solid dispersion rely on having 100% amorphous
content? What specifications are appropriate for crystalline content within an amorphous …

The particle drifting effect: a combined function of colloidal and drug properties

DH Yang, S Najafian, B Chaudhuri… - Molecular Pharmaceutics, 2024 - ACS Publications
The particle drifting effect, where nanosized colloidal drug particles overcome the diffusional
resistance of the aqueous boundary layer adjacent to the intestinal wall and increase drug …

Impact of colloidal drug-rich droplet size and amorphous solubility on drug membrane permeability: A comprehensive analysis

K Ueda, S Takemoto, K Higashi, K Moribe - Journal of Pharmaceutical …, 2025 - Elsevier
This study aimed to investigate the impact of amorphous solubility and colloidal drug-rich
droplets on drug absorption. The amorphous solubility of cilnidipine (CND) in AS-HF grade …

Biorelevant dissolution method considerations for the appropriate evaluation of amorphous solid dispersions: are two stages necessary?

Z Wang, H Lou, TJ Dening, MJ Hageman - Journal of Pharmaceutical …, 2023 - Elsevier
Biorelevant dissolution testing has been widely used to better understand a drug or
formulation's behavior in the human gastrointestinal (GI) tract. The successful evaluation of …

Self-nanomicellizing solid dispersion: A promising platform for oral drug delivery

W Chen, A Yan, T Sun, X Wang, W Sun… - Colloids and Surfaces B …, 2024 - Elsevier
Amorphous solid dispersion (ASD) has been widely used to enhance the oral bioavailability
of water-insoluble drugs for oral delivery because of its advantages of enhancing solubility …

Growth mechanisms of amorphous nanoparticles in solution and during heat drying

A Narula, P Chakravarty, N Li - Journal of Pharmaceutical Sciences, 2025 - Elsevier
The purpose of this study was twofold: to identify the growth mechanisms of amorphous
nanoparticles in solution and during the drying process at high temperatures, and to guide …

Dissolution Mechanisms of Amorphous Solid Dispersions: Application of Ternary Phase Diagrams To Explain Release Behavior

A Deac, C Luebbert, Q Qi, RM Courtney… - Molecular …, 2024 - ACS Publications
The use of amorphous solid dispersions (ASDs) in commercial drug products has increased
in recent years due to the large number of poorly soluble drugs in the pharmaceutical …

[HTML][HTML] Ex vivo permeability study of poorly soluble drugs across gastrointestinal membranes: acceptor compartment media composition

A Sitovs, V Mohylyuk - Drug Discovery Today, 2024 - Elsevier
Highlights•Acceptor compartment media compositions used in ex vivo permeability studies
for poorly soluble drugs are critically evaluated.•An algorithm for selecting suitable solubility …